Chiral Chromatography Columns Industry Overview, Competitive Landscape and Forecasts 2030
The global chiral chromatography columns market was valued at USD 109.7 million in 2024 and is projected to reach USD 141.5 million by 2030, expanding at a CAGR of 4.4% from 2025 to 2030. Chiral chromatography columns are essential analytical tools used for separating enantiomers mirror-image molecules that can have different biological activities. These columns are widely applied across pharmaceuticals, biotechnology, environmental testing, and food industries due to the growing need for precise analysis and quality control.
A major factor contributing to market growth is the continuous advancement in chromatography technologies and strategic industry developments. For example, in February 2022, Sartorius acquired Novasep’s chromatography division after receiving clearance from the U.S. Federal Trade Commission. The acquisition expanded Sartorius’s portfolio with advanced chromatography systems designed to handle smaller biomolecules such as insulin, oligonucleotides, and peptides, along with state-of-the-art solutions for continuous biologics manufacturing. Such advancements are driving the demand for more specialized and efficient chiral chromatography solutions.
In addition, emerging economies such as India, China, and Brazil represent high-growth opportunities for market players. These countries are witnessing a surge in life sciences research, pharmaceutical manufacturing, and adoption of analytical technologies, which is increasing the demand for chiral chromatography columns. Their expanding healthcare infrastructure and focus on modern drug development further strengthen the outlook for sustainable demand.
Another important growth avenue is the increasing focus on green chromatography. With sustainability becoming a priority in analytical sciences, laboratories are adopting practices aimed at reducing waste generation, energy consumption, and reliance on hazardous solvents and chemicals. This shift is not only helping minimize environmental impact but is also encouraging manufacturers to innovate eco-friendly chromatography systems and columns, thereby creating new opportunities in the market.
Key Market Trends & Insights:
- Regional Insights: North America led the global market, accounting for the largest revenue share of 38.0% in 2024. The dominance of the region is supported by strong pharmaceutical R&D activity, well-established healthcare infrastructure, and the presence of major market players. Asia Pacific is projected to grow at the fastest CAGR of 4.7% during the forecast period. Factors such as growing investment in life sciences, the rising number of clinical trials, and increasing adoption of advanced analytical instruments across China, India, and Japan are key growth drivers.
- Type Insights: High-performance liquid chromatography (HPLC) dominated the market with the largest revenue share of 48.6% in 2024, as it is widely preferred for chiral separations in pharmaceuticals and biotechnology applications. Gas chromatography columns are projected to grow at a CAGR of 4.2%, driven by their growing use in environmental testing and the food industry for analyzing chiral compounds.
- Product Insights: Pre-packed column systems held the dominant position with a 76.6% revenue share in 2024, owing to their ease of use, high efficiency, and reduced preparation time. Empty columns are expected to grow at a CAGR of 3.4% over the forecast period, primarily driven by customization needs in research laboratories.
- Material Insights: The metal-based segment accounted for the largest revenue share of 41.3% in 2024, reflecting their strength, durability, and suitability for high-pressure chromatography. The plastic-based segment is anticipated to grow at a CAGR of 4.1%, supported by their affordability, lightweight design, and suitability for specific applications.
- End-use Insights: The pharmaceutical & biotechnology sector dominated the market with a 26.4% revenue share in 2024, as chiral chromatography plays a critical role in drug development and regulatory compliance. The environmental testing laboratories segment is projected to witness the fastest growth at a CAGR of 5.1%, reflecting rising demand for precise analysis of pollutants, contaminants, and chiral compounds in environmental samples.
Order a free sample PDF of the Chiral Chromatography Columns Market Intelligence Study, published by Grand View Research.
Market Size & Forecast:
- 2024 Market Size: USD 109.7 Million
- 2030 Projected Market Size: USD 141.5 Million
- CAGR (2025-2030): 4.4%
- North America: Largest market in 2024
Key Companies & Market Share Insights:
The chiral chromatography columns market is moderately consolidated, with several global and regional players actively competing. Key players include Agilent Technologies, Inc., GE Healthcare, Danaher, and Thermo Fisher Scientific, Inc., which leverage their strong R&D capabilities, broad product portfolios, and extensive global distribution networks to maintain their leadership.
- Veolia Water Technologies, an American company specializing in life sciences and clinical research, offers a range of chromatography columns, including solutions for HPLC and UPLC systems, as well as chiral chromatography applications.
- Danaher Corporation, headquartered in Washington, U.S., operates through its Life Sciences division, providing chromatography columns globally to support research, diagnostics, and biotechnology applications.
These companies, along with other players in the market, are focusing on strategies such as mergers and acquisitions, partnerships, product innovations, and regional expansions to strengthen their positions and capture new growth opportunities.
Explore our latest blogs: Global Industry Herald
Conclusion:
The chiral chromatography columns market is set to grow steadily, supported by advancements in chromatography technologies, increasing pharmaceutical and biotechnology research, and the rising emphasis on sustainable green chromatography practices. While North America currently holds the largest share due to its strong R&D ecosystem and established industry players, Asia Pacific is expected to record the fastest growth driven by expanding research activities and healthcare infrastructure. With growing applications across pharmaceuticals, biotechnology, and environmental testing, along with active participation from leading global companies, the market is positioned to remain an essential part of analytical and life sciences industries.
- Art
- Causes
- Crafts
- Dance
- Drinks
- Film
- Fitness
- Food
- Spellen
- Gardening
- Health
- Home
- Literature
- Music
- Networking
- Other
- Party
- Religion
- Shopping
- Sports
- Theater
- Wellness
- IT, Cloud, Software and Technology